[Hiring] Senior Director, Global Pricing System and Reporting @Revolution Medicines

Role Description

Revolution Medicines is seeking a strategic, collaborative, and execution-oriented Senior Director, Global Pricing System & Reporting, to lead the development and management of global pricing systems, data governance, and reporting capabilities across the company’s portfolio. This role will establish a reliable, scalable infrastructure to support pricing decisions, governance, launch planning, and monitoring of pricing performance across markets.

Working closely with Global Value, Access and Pricing teams, country Market Access teams, Finance, IT, Commercial Operations, and Trade and Distribution, this leader will translate business needs into integrated systems, standardized processes, and actionable reporting. The role will ensure that pricing information is accurate, accessible, and consistently managed throughout the product lifecycle.

Key Responsibilities

• Global Pricing Systems and Infrastructure
  • Develop and execute the global pricing systems roadmap, aligning capabilities with portfolio growth, geographic expansion, and evolving business requirements.
  • Serve as the business owner for global pricing platforms, defining requirements, prioritizing enhancements, and overseeing implementation, adoption, and ongoing performance.
  • Establish capabilities to capture and manage list prices, net prices, reimbursement status, pricing assumptions, approved price corridors, and pricing decision histories.
  • Partner with IT and other system owners to integrate pricing platforms with relevant finance, commercial, and distribution systems.
• Pricing Data Governance and Quality
  • Establish global standards for pricing data definitions, ownership, validation, access, and maintenance.
  • Develop a consistent approach to comparing prices across countries, currencies, strengths, pack sizes, dosing regimens, and treatment durations.
  • Implement controls to ensure data completeness, accuracy, timeliness, confidentiality, and traceability.
  • Maintain a reliable record of pricing approvals, country submissions, reimbursement outcomes, and subsequent price changes.
• Global Pricing Reporting and Insights
  • Develop standardized dashboards and executive reporting to monitor global pricing performance, launch readiness, reimbursement progress, and adherence to approved pricing guidance.
  • Establish meaningful metrics covering price realization, list-to-net trends, price changes, governance compliance, and reporting quality.
  • Partner with Pricing Strategy and Finance to support scenario analysis, business planning, and lifecycle pricing assessments.
  • Translate complex pricing information into clear insights for leadership and governance committees.
• Pricing Governance and Process Excellence
  • Design and maintain system-enabled workflows for pricing proposals, reviews, approvals, escalations, and periodic reassessments.
  • Support global pricing committees through standardized submission templates, decision records, and approval tracking.
• Leadership and Cross-Functional Collaboration
  • Build and lead a high-performing team responsible for pricing systems, data management, and reporting.
  • Establish clear accountability and effective working relationships across Global Pricing, country teams, Finance, IT, and Commercial Operations.
  • Manage external partners and departmental resources to deliver agreed priorities.

Qualifications

• Bachelor’s degree in business, finance, economics, information systems, analytics, or a related field; advanced degree preferred.
• At least 12 years of relevant experience in the pharmaceutical or biotechnology industry, including substantial experience in global pricing operations, pricing systems, analytics, or commercial data management.
• Demonstrated success implementing or improving global pricing platforms, data governance frameworks, and executive reporting.
• Strong understanding of pharmaceutical pricing, reimbursement, international reference pricing, and product lifecycle considerations.
• Experience translating business requirements into technology solutions and leading complex cross-functional initiatives.
• Proficiency with business intelligence and reporting tools; familiarity with data integration and enterprise systems.

Benefits

• Competitive cash compensation.
• Robust equity awards.
• Strong benefits.
• Significant learning and development opportunities.

Company Description

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS.

Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.